Education
About Us
Working with TipRanks
Follow Us
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
Integra Lifesciences (IART) Ownership Overview
3.28% Insiders
31.64% Mutual Funds
20.09% Other Institutional Investors
27.95% ETFs
17.03% Public Companies and
Individual Investors
The ownership structure of Integra Lifesciences (IART) stock is a mix of institutional, retail, and individual investors. Approximately 79.69% of the company’s stock is owned by Institutional Investors, 3.28% is owned by Insiders, and 17.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 04, 2024 | Eric Schwartz Evp, Clo & Sec | xxxxxxxxxxxxx | $100081 |
| Dec 03, 2024 | Michael J. Mcbreen Evp & President, Css | xxxxxxxxxxxxx | $41055 |
| Aug 20, 2024 | Jeffrey Mosebrook Svp, Fin & Princ Acct Officer | xxxxxxxxxxxxx | $25690 |
| May 24, 2024 | Stuart Essig Director | xxxxxxxxxxxxx | $1499742 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $1070450 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $2512263 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $3016440 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,498,541 | Institution | 13.60% | 242,726,268 | |
| 6,868,771 | Institution | 8.90% | 158,805,986 | |
| 5,820,036 | Institution | 7.54% | 134,559,232 | |
| 3,430,268 | Institution | 4.44% | 79,307,796 | |
| 2,430,000 | Institution | 3.15% | 56,181,600 | |
| 2,000,000 | Institution | 2.59% | 46,240,000 | |
| 1,753,434 | Insider | 2.27% | 40,539,394 | |
| 1,691,400 | Institution | 2.19% | 39,105,168 | |
| 1,467,632 | Institution | 1.90% | 33,931,652 | |
| 1,321,360 | Institution | 1.71% | 30,549,843 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,820,036 | Institution | 7.54% | 134,559,232 | |
| 3,430,268 | Institution | 4.44% | 79,307,796 | |
| 1,691,400 | Institution | 2.19% | 39,105,168 | |
| 1,178,305 | Institution | 1.53% | 27,242,412 | |
| 1,118,383 | Institution | 1.45% | 25,857,015 | |
| 885,112 | Institution | 1.15% | 20,463,789 | |
| 796,433 | Institution | 1.03% | 18,413,531 | |
| 794,410 | Institution | 1.03% | 18,366,759 | |
| 765,677 | Institution | 0.99% | 17,702,452 | |
| 661,987 | Institution | 0.86% | 15,305,139 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,189,439 | Institution | 5.43% | 93,633,962 | |
| 2,257,075 | Institution | 2.92% | 120,708,371 | |
| 2,058,279 | Institution | 2.67% | 47,772,656 | |
| 1,822,615 | Institution | 2.36% | 42,138,859 | |
| 1,670,195 | Institution | 2.16% | 37,880,023 | |
| 1,101,708 | Institution | 1.43% | 25,570,643 | |
| 1,015,960 | Institution | 1.32% | 23,580,432 | |
| 705,502 | Institution | 0.91% | 15,767,970 | |
| 620,042 | Institution | 0.80% | 14,335,371 | |
| 584,733 | Institution | 0.76% | 13,068,783 |
FAQ
Who Owns Integra Lifesciences Holdings Corp. (IART)?
According to the latest TipRanks data, approximately 20.09% of the company's stock is held by institutional investors, 3.28% is held by insiders, and 17.03% is held by retail investors.
What percentage of Integra Lifesciences Holdings Corp. (IART) stock is held by institutional investors?
According to the latest TipRanks data, approximately 20.09% of Integra Lifesciences Holdings Corp. (IART) stock is held by institutional investors.
What percentage of Integra Lifesciences Holdings Corp. (IART) stock is held by retail investors?
According to the latest TipRanks data, approximately 17.03% of Integra Lifesciences Holdings Corp. (IART) stock is held by retail investors.
Who owns the most shares of Integra Lifesciences Holdings Corp. (IART)?
iShares owns the most shares of Integra Lifesciences Holdings Corp. (IART).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.